Position in CGC
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$301,757
-$103,511 QoQ
Shares Held
317,974
-10.6% QoQ
Ownership
0.075%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in CGC Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026HRT FINANCIAL LP holds $86,644,803 across 27 Drug Manufacturers - Specialty & Generic names. CGC ranks #20 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
66,842 | $39,635,969 | |
| 2 | HLN |
Haleon plc
|
1,100,190 | $11,012,901 | |
| 3 | HIMS |
Hims & Hers Health, Inc.
|
284,622 | $5,908,752 | |
| 4 | TEVA |
Teva Pharmaceutical Industries Ltd
|
140,222 | $4,223,486 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
26,404 | $3,478,462 | |
| 6 | LQDA |
Liquidia Corp
|
86,687 | $3,271,567 | |
| 7 | ALKS |
Alkermes plc.
|
81,989 | $2,899,131 | |
| 8 | TAK |
Takeda Pharmaceutical Co Ltd
|
126,074 | $2,334,890 |
All Filings in CGC
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $301,757 | 317,974 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $405,268 | 355,499 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $1,814,883 | 1,243,071 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $541,604 | 443,938 | Shares | Defined | 2025-08-14 | |
| No filing history on record for this holder in this stock. | ||||||